| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |